MedPath

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
Registration Number
NCT00664248
Lead Sponsor
Dow Pharmaceutical Sciences
Brief Summary

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1414
Inclusion Criteria
  • Presence of inflammatory and non-inflammatory lesions
Exclusion Criteria
  • Dermatological conditions of the face other than acne that could interfere with clinical evaluations
  • Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1IDP-110-
4Vehicle-
3Benzoyl peroxide-
2Clindamycin-
Primary Outcome Measures
NameTimeMethod
Change from baseline in number of lesions12 weeks
Secondary Outcome Measures
NameTimeMethod
Change from baseline in global severity12 weeks

Trial Locations

Locations (35)

Advanced Clinical Research - Jordan Valley

๐Ÿ‡บ๐Ÿ‡ธ

West Jordan, Utah, United States

International Dermatology Research, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

The Nevada Center for Dermatology

๐Ÿ‡บ๐Ÿ‡ธ

Reno, Nevada, United States

Advanced Healthcare

๐Ÿ‡บ๐Ÿ‡ธ

Milwaukee, Wisconsin, United States

Henry Ford Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

Oregon Medical Center, PC

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Mediprobe Research

๐Ÿ‡จ๐Ÿ‡ฆ

New London, Ontario, Canada

Longmont Medical Research Network

๐Ÿ‡บ๐Ÿ‡ธ

Longmont, Colorado, United States

Cherry Creek Dermatology Research Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

Dermatology Resarch Center

๐Ÿ‡บ๐Ÿ‡ธ

Salt Lake City, Utah, United States

University of Alabama, Birmingham

๐Ÿ‡บ๐Ÿ‡ธ

Birmingham, Alabama, United States

Affiliated Research Institute - Dermatology

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Solano Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Vallejo, California, United States

Clinical Research Specialists

๐Ÿ‡บ๐Ÿ‡ธ

West Santa Monica, California, United States

Dermatology Specialists, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Vista, California, United States

Total Skin and Beauty Dermatology Center

๐Ÿ‡บ๐Ÿ‡ธ

Birmingham, Alabama, United States

New Haven Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Wilmington, North Carolina, United States

Triangle Medical Research Associates

๐Ÿ‡บ๐Ÿ‡ธ

Cary, North Carolina, United States

Academic Dermatology

๐Ÿ‡บ๐Ÿ‡ธ

Albuquerque, New Mexico, United States

Dermatology Research of Arkansas

๐Ÿ‡บ๐Ÿ‡ธ

Little Rock, Arkansas, United States

Unifour Medical Research Associates

๐Ÿ‡บ๐Ÿ‡ธ

Hickory, North Carolina, United States

Northwest Cutaneous Research Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Dermatology Research Associates

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

The Center for Skin Research

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Progressive Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

Rivergate Dermatology

๐Ÿ‡บ๐Ÿ‡ธ

Goodlettsville, Tennessee, United States

Dermatology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Knoxville, Tennessee, United States

Medical Affiliated Research Center, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Huntsville, Alabama, United States

Therapeutics Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Office of Scott Glazer, MD

๐Ÿ‡บ๐Ÿ‡ธ

Buffalo Grove, Illinois, United States

Wake Research Associates, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

Dermatology and Skin Surgery Centre

๐Ÿ‡ง๐Ÿ‡ฟ

Belize City, Belize

University of California, San Diego, Pediatric and Adolescent Dermatology

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

FXM Research

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Tennessee Clinical Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath